For Immediate Release
Chapel Hill, NC ̶ May 31, 2016 ̶ Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that the company was named the 2016 Best CRO by Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham and Chapel Hill region of North Carolina, where Rho is headquartered. Rho was also honored with this award in 2015.
Part of the publication’s annual Life Sciences Awards, the “Best CRO” recognizes individuals and organizations contributing to the robust growth of the life sciences industry in the Research Triangle Park (RTP) area of North Carolina. This year’s winners were selected to reflect the power, influence and intellect present in the region’s biology, biotechnology, genomics, neuroscience and pharmacology communities.
“It is an honor to be named the Best CRO by the Triangle Business Journal for the second year in a row, and to be included among life science industry leaders in the RTP region,” said Laura Helms Reece, DrPH, chief executive officer for Rho. “This award is a testament to the hard work and customer focus of Rho’s employees, and their commitment to exceptional service in providing customers the clinical trial support they need. As an employee-centered CRO grounded in North Carolina, we are dedicated to continuing to grow the life sciences industry and improve the business climate, both in the RTP region and across the state.”
Rho is one of 13 companies selected as finalists for the Life Sciences Award. Rho and the other winners were recognized at an awards luncheon held May 26, 2016, in Cary, North Carolina.
To learn more about Rho, please visit www.rhoworld.com.
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For more than 32 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Twitter.